{"hands_on_practices": [{"introduction": "The American Society of Anesthesiologists (ASA) Physical Status classification is the cornerstone of preoperative risk assessment, providing a universal language to summarize a patient's overall physiological state. This practice will hone your ability to synthesize diverse clinical data from patient vignettes into a single, actionable risk category. Mastering this skill is fundamental to guiding anesthetic strategy, resource allocation, and perioperative planning. [@problem_id:4660009]", "problem": "A surgeon must assign and justify the American Society of Anesthesiologists (ASA) Physical Status classification for three patients as part of preoperative patient evaluation and optimization. The ASA Physical Status system categorizes risk based on the presence and severity of systemic disease and its impact on functional capacity and physiologic stability. Use the core definitions of ASA Physical Status categories as the fundamental base: absence of systemic disease versus mild systemic disease without substantive functional limitation, severe systemic disease with substantive functional limitation, and severe systemic disease that is a constant threat to life. Your task is to determine the ASA class for each patient grounded in those definitions and to note key perioperative implications that follow from your classification, including optimization needs, monitoring intensity, and whether emergency status modifies risk.\n\nVignette $1$: A $52$-year-old woman is scheduled for elective laparoscopic cholecystectomy. She has well-controlled hypertension (HTN) on a single angiotensin receptor blocker, type $2$ diabetes mellitus (DM) with glycated hemoglobin (HbA1c) $6.8\\%$, and body mass index (BMI) $32$ $\\mathrm{kg/m^2}$. She is a non-smoker, walks briskly daily, and can climb $2$ flights of stairs without limitation, consistent with more than $7$ Metabolic Equivalent of Task (METs). She has no known coronary artery disease (CAD), heart failure, chronic kidney disease (CKD), or chronic obstructive pulmonary disease (COPD). Physical examination and basic laboratory work are within normal limits.\n\nVignette $2$: A $68$-year-old man is scheduled for elective right hemicolectomy for colon adenocarcinoma. Comorbidities include ischemic cardiomyopathy with left ventricular ejection fraction (EF) $35\\%$ and New York Heart Association (NYHA) class II symptoms, prior myocardial infarction (MI) $2$ years ago, CKD stage $3$ with estimated glomerular filtration rate (eGFR) $45$ $\\mathrm{mL/min/1.73\\,m^2}$, and moderate COPD with forced expiratory volume in $1$ second ($\\mathrm{FEV}_{1}$) $55\\%$ predicted, controlled on long-acting bronchodilators. He also has obstructive sleep apnea (OSA) adherent to continuous positive airway pressure (CPAP). He can perform light housework but becomes dyspneic with moderate exertion, approximating $4$ METs. He has no active angina, no decompensated heart failure, and his oxygen saturation is $95\\%$ on room air.\n\nVignette $3$: A $74$-year-old woman presents with acute small-bowel obstruction due to a strangulating ventral hernia and is scheduled for urgent open exploration. She has decompensated congestive heart failure (CHF) with EF $20\\%$, orthopnea, and paroxysmal nocturnal dyspnea; recent episodes of chest pain at rest concerning for unstable angina; oxygen-dependent COPD with baseline partial pressure of carbon dioxide (PaCO$_2$) $56$ $\\mathrm{mmHg}$; and acute kidney injury with serum creatinine $3.2$ $\\mathrm{mg/dL}$ rising from baseline $1.1$ $\\mathrm{mg/dL}$ in the last $48$ hours. She is hemodynamically stable on admission without vasopressors, but her conditions remain tenuous. The case is urgent rather than elective, and by ASA convention would carry the emergency suffix ($E$) when applicable.\n\nWhich option correctly lists the ASA Physical Status class for Patient $1$, Patient $2$, and Patient $3$ respectively?\n\nA. Patient $1$: ASA $2$; Patient $2$: ASA $3$; Patient $3$: ASA $4$\n\nB. Patient $1$: ASA $1$; Patient $2$: ASA $3$; Patient $3$: ASA $4$\n\nC. Patient $1$: ASA $2$; Patient $2$: ASA $4$; Patient $3$: ASA $4$\n\nD. Patient $1$: ASA $3$; Patient $2$: ASA $3$; Patient $3$: ASA $4$\n\nE. Patient $1$: ASA $2$; Patient $2$: ASA $3$; Patient $3$: ASA $5$", "solution": "The problem statement is evaluated for validity prior to attempting a solution.\n\n### Step 1: Extract Givens\n\nThe problem provides the following data and definitions for the American Society of Anesthesiologists (ASA) Physical Status classification system:\n*   **Core Definitions:**\n    *   Absence of systemic disease.\n    *   Mild systemic disease without substantive functional limitation.\n    *   Severe systemic disease with substantive functional limitation.\n    *   Severe systemic disease that is a constant threat to life.\n*   **Vignette $1$:** A $52$-year-old woman for elective laparoscopic cholecystectomy.\n    *   Comorbidities: Well-controlled hypertension ($\\mathrm{HTN}$) on one angiotensin receptor blocker, type $2$ diabetes mellitus ($\\mathrm{DM}$) with glycated hemoglobin ($\\mathrm{HbA1c}$) $6.8\\%$, body mass index ($\\mathrm{BMI}$) $32$ $\\mathrm{kg/m^2}$.\n    *   Negative History: Non-smoker, no known coronary artery disease ($\\mathrm{CAD}$), heart failure ($\\mathrm{HF}$), chronic kidney disease ($\\mathrm{CKD}$), or chronic obstructive pulmonary disease ($\\mathrm{COPD}$).\n    *   Functional Status: Excellent, can climb $2$ flights of stairs without limitation, equivalent to more than $7$ Metabolic Equivalent of Task ($\\mathrm{METs}$).\n    *   Examination: Physical exam and basic labs are within normal limits.\n*   **Vignette $2$:** A $68$-year-old man for elective right hemicolectomy.\n    *   Comorbidities: Ischemic cardiomyopathy with left ventricular ejection fraction ($\\mathrm{EF}$) $35\\%$, New York Heart Association ($\\mathrm{NYHA}$) class $\\mathrm{II}$ symptoms, prior myocardial infarction ($\\mathrm{MI}$) $2$ years ago, $\\mathrm{CKD}$ stage $3$ with estimated glomerular filtration rate ($\\mathrm{eGFR}$) $45$ $\\mathrm{mL/min/1.73\\,m^2}$, moderate $\\mathrm{COPD}$ with forced expiratory volume in $1$ second ($\\mathrm{FEV}_{1}$) $55\\%$ predicted, obstructive sleep apnea ($\\mathrm{OSA}$) adherent to continuous positive airway pressure ($\\mathrm{CPAP}$).\n    *   Functional Status: Limited, can perform light housework but becomes dyspneic with moderate exertion, approximating $4$ $\\mathrm{METs}$.\n    *   Current Status: Stable, no active angina, no decompensated heart failure, oxygen saturation $95\\%$ on room air.\n*   **Vignette $3$:** A $74$-year-old woman for urgent open exploration of a strangulating ventral hernia.\n    *   Comorbidities: Decompensated congestive heart failure ($\\mathrm{CHF}$) with $\\mathrm{EF}$ $20\\%$, orthopnea, and paroxysmal nocturnal dyspnea; recent chest pain at rest concerning for unstable angina; oxygen-dependent $\\mathrm{COPD}$ with baseline partial pressure of carbon dioxide ($\\mathrm{PaCO}_2$) $56$ $\\mathrm{mmHg}$; acute kidney injury with serum creatinine $3.2$ $\\mathrm{mg/dL}$ (baseline $1.1$ $\\mathrm{mg/dL}$).\n    *   Current Status: Tenuous but hemodynamically stable on admission without vasopressors.\n    *   Urgency: Urgent, designated with an 'E' suffix.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem is scientifically grounded, utilizing the standard and widely accepted ASA Physical Status classification system. The patient vignettes are medically plausible and contain objective, quantifiable data (e.g., $\\mathrm{HbA1c}$, $\\mathrm{EF}$, $\\mathrm{eGFR}$, $\\mathrm{FEV}_{1}$) consistent with real-world clinical scenarios. The provided definitions, while simplified, correspond accurately to the core concepts of ASA classes $1$ through $4$. The problem is self-contained, with each vignette providing sufficient information to perform the classification. There are no contradictions, ambiguities, or violations of scientific principles. The problem is well-posed and objective.\n\n### Step 3: Verdict and Action\n\nThe problem statement is **valid**. A solution will be derived by applying the provided definitions to each patient vignette.\n\n### Derivation of Solution\n\nThe ASA Physical Status classification is determined for each patient based on the severity of their systemic diseases and the resulting functional limitations, as per the provided framework.\n\n**Patient 1 Analysis:**\n*   This $52$-year-old woman has multiple systemic diseases: hypertension ($\\mathrm{HTN}$), type $2$ diabetes mellitus ($\\mathrm{DM}$), and Class I obesity ($\\mathrm{BMI} = 32$ $\\mathrm{kg/m^2}$). This definitively excludes ASA class $1$ (\"absence of systemic disease\").\n*   However, her diseases are characterized as \"well-controlled\" (single medication for $\\mathrm{HTN}$, $\\mathrm{HbA1c}$ of $6.8\\%$) and, critically, they do not impose any \"substantive functional limitation.\" Her excellent functional capacity of greater than $7$ $\\mathrm{METs}$ confirms this.\n*   This clinical picture perfectly matches the definition of \"mild systemic disease without substantive functional limitation.\"\n*   Therefore, Patient $1$ is classified as **ASA $2$**.\n\n**Patient 2 Analysis:**\n*   This $68$-year-old man presents with multiple, severe chronic conditions affecting several major organ systems.\n*   Cardiac: Ischemic cardiomyopathy with a moderately reduced ejection fraction ($\\mathrm{EF}$ $35\\%$) and symptomatic heart failure ($\\mathrm{NYHA}$ class $\\mathrm{II}$). A history of $\\mathrm{MI}$ more than $3$ months prior ($2$ years ago) with these sequelae is a significant factor.\n*   Renal: Chronic kidney disease stage $3$ with an $\\mathrm{eGFR}$ of $45$ $\\mathrm{mL/min/1.73\\,m^2}$ represents a moderate impairment.\n*   Pulmonary: Moderate $\\mathrm{COPD}$ ($\\mathrm{FEV}_{1}$ $55\\%$ predicted) requiring long-acting bronchodilators.\n*   These conditions result in a \"substantive functional limitation,\" as evidenced by his poor exercise tolerance of approximately $4$ $\\mathrm{METs}$.\n*   This scenario corresponds directly to the definition of \"severe systemic disease with substantive functional limitation.\" The diseases are chronic and described as currently stable (\"no active angina, no decompensated heart failure\"), not an immediate threat to life.\n*   Therefore, Patient $2$ is classified as **ASA $3$**.\n\n**Patient 3 Analysis:**\n*   This $74$-year-old woman is acutely ill with multiple life-threatening conditions.\n*   Cardiac: She has decompensated heart failure with a severely reduced ejection fraction ($\\mathrm{EF}$ $20\\%$) and active symptoms (orthopnea, $\\mathrm{PND}$). Furthermore, she has symptoms suggestive of unstable angina.\n*   Pulmonary: She has end-stage, oxygen-dependent $\\mathrm{COPD}$ with chronic respiratory failure (hypercarbia with $\\mathrm{PaCO}_2$ $56$ $\\mathrm{mmHg}$).\n*   Renal: She has acute-on-chronic kidney failure.\n*   These conditions are severe, unstable, and actively decompensated. Collectively, they represent a \"constant threat to life,\" independent of the surgical problem. The patient's condition is tenuous despite being hemodynamically stable without vasopressors on admission. This clinical state fits the definition for ASA class $4$.\n*   She is not yet \"moribund\" (ASA $5$), a state implying imminent demise, often associated with profound shock or multi-organ failure unresponsive to therapy. The fact that she is stable without vasopressors upon admission argues for ASA $4$ over ASA $5$. The urgent nature of her surgery would add an 'E' modifier to her classification, making it ASA $4$E. The question asks for the numerical class.\n*   Therefore, Patient $3$ is classified as **ASA $4$**.\n\n**Summary of Classifications:**\n*   Patient $1$: ASA $2$\n*   Patient $2$: ASA $3$\n*   Patient $3$: ASA $4$\n\n### Option-by-Option Analysis\n\n*   **A. Patient $1$: ASA $2$; Patient $2$: ASA $3$; Patient $3$: ASA $4$**\n    This option matches the derived classifications for all three patients. Patient $1$ has mild, controlled disease without functional limitation. Patient $2$ has severe, chronic disease with significant functional limitation. Patient $3$ has severe, decompensated disease that is a constant threat to life.\n    **Verdict: Correct.**\n\n*   **B. Patient $1$: ASA $1$; Patient $2$: ASA $3$; Patient $3$: ASA $4$**\n    This option incorrectly classifies Patient $1$ as ASA $1$. An ASA $1$ patient is normal and healthy, which is incorrect for a patient with hypertension, diabetes, and obesity.\n    **Verdict: Incorrect.**\n\n*   **C. Patient $1$: ASA $2$; Patient $2$: ASA $4$; Patient $3$: ASA $4$**\n    This option incorrectly classifies Patient $2$ as ASA $4$. While his diseases are severe, they are chronic and described as stable. They cause functional limitation (characteristic of ASA $3$) but are not an immediate, constant threat to life (characteristic of ASA $4$).\n    **Verdict: Incorrect.**\n\n*   **D. Patient $1$: ASA $3$; Patient $2$: ASA $3$; Patient $3$: ASA $4$**\n    This option incorrectly classifies Patient $1$ as ASA $3$. ASA $3$ implies severe disease with substantive functional limitation. This patient has excellent functional capacity ($7$ METs), which is inconsistent with an ASA $3$ classification.\n    **Verdict: Incorrect.**\n\n*   **E. Patient $1$: ASA $2$; Patient $2$: ASA $3$; Patient $3$: ASA $5$**\n    This option incorrectly classifies Patient $3$ as ASA $5$. ASA $5$ denotes a moribund patient not expected to survive without the operation. The patient's hemodynamic stability on admission without vasopressors, though tenuous, makes ASA $4$ (a constant threat to life) a more precise classification than ASA $5$.\n    **Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "4660009"}, {"introduction": "While the ASA class provides a global overview, specific organ system risk must also be quantified, particularly for the cardiovascular system. The Revised Cardiac Risk Index (RCRI) is a validated and indispensable tool for predicting major adverse cardiac events (MACE) in noncardiac surgery. This exercise requires you to systematically apply the RCRI criteria to a patient's profile, calculate the risk score, and interpret its implications for further management, a core workflow in modern perioperative medicine. [@problem_id:4659946]", "problem": "A $70$-year-old man is scheduled for an elective open sigmoid colectomy for complicated diverticulitis, which is an intraperitoneal operation. His past medical history includes type $2$ diabetes mellitus treated with basal-bolus insulin, a prior ischemic cerebrovascular accident with mild residual hemiparesis, and chronic kidney disease with a most recent preoperative serum creatinine of $2.1$ mg/dL. He denies chest pain and orthopnea, has no known ischemic heart disease and no history of congestive heart failure. He can perform light housework but cannot climb one flight of stairs without stopping, consistent with functional capacity of $4$ metabolic equivalents (METs). There are no active cardiac conditions identified on history, examination, or electrocardiogram.\n\nUsing only well-tested perioperative risk stratification facts and definitions, identify the qualifying elements for the Revised Cardiac Risk Index (RCRI), compute the total RCRI score, and then map this score to the estimated probability of a major adverse cardiac event (MACE) according to the original risk categories of the index. Express the final probability as a pure decimal number without a percent sign, and round your answer to three significant figures.\n\nBased on this computed risk, apply the standard decision framework from professional society perioperative guidelines for general surgery to determine whether further noninvasive cardiac testing would be warranted; justify the decision qualitatively in your reasoning. Your final submitted answer must be only the computed MACE probability as specified above.", "solution": "The problem requires a three-part analysis based on a provided clinical vignette: first, a quantitative risk stratification using the Revised Cardiac Risk Index (RCRI); second, mapping this risk score to a probability of a major adverse cardiac event (MACE); and third, a qualitative application of clinical guidelines to decide on further preoperative testing. The final answer is to be the computed MACE probability.\n\nThe validation of the problem statement confirms that it is scientifically grounded, well-posed, and objective. It provides a realistic clinical scenario with all necessary data points to apply the specified risk assessment tool. The problem is valid.\n\nThe solution proceeds by first identifying the six independent predictors of major cardiac complications as defined by the RCRI (Lee et al., 1999). Each point in the index corresponds to one of these predictors.\n\nThe six criteria for the Revised Cardiac Risk Index are:\n1.  High-risk surgery: Intraperitoneal, intrathoracic, or suprainguinal vascular surgery.\n2.  History of ischemic heart disease (IHD): History of myocardial infarction or a positive exercise test, current chest pain considered to be ischemic, use of nitrate therapy, or ECG with pathological Q waves.\n3.  History of congestive heart failure (CHF): History of CHF, paroxysmal nocturnal dyspnea, orthopnea, bilateral rales, or S3 gallop.\n4.  History of cerebrovascular disease (CVA): History of transient ischemic attack or stroke.\n5.  Preoperative treatment with insulin.\n6.  Preoperative serum creatinine $ 2.0$ mg/dL.\n\nNext, we evaluate the patient's clinical data against each of these six criteria to compute the total RCRI score.\n\n1.  **High-risk surgery:** The patient is scheduled for an \"elective open sigmoid colectomy,\" which is specified as an \"intraperitoneal operation.\" This type of major abdominal surgery is classified as high-risk. Therefore, this criterion is met. This contributes $1$ point to the score.\n\n2.  **History of ischemic heart disease:** The problem explicitly states \"no known ischemic heart disease\" and the patient \"denies chest pain.\" Therefore, this criterion is not met. This contributes $0$ points.\n\n3.  **History of congestive heart failure:** The problem explicitly states \"no history of congestive heart failure\" and the patient \"denies... orthopnea.\" Therefore, this criterion is not met. This contributes $0$ points.\n\n4.  **History of cerebrovascular disease:** The problem states the patient has a \"prior ischemic cerebrovascular accident.\" Therefore, this criterion is met. This contributes $1$ point.\n\n5.  **Preoperative treatment with insulin:** The problem states the patient has \"type $2$ diabetes mellitus treated with basal-bolus insulin.\" The use of insulin for diabetes management meets this criterion, regardless of the type of diabetes. Therefore, this criterion is met. This contributes $1$ point.\n\n6.  **Preoperative serum creatinine $ 2.0$ mg/dL:** The problem states the patient has \"chronic kidney disease with a most recent preoperative serum creatinine of $2.1$ mg/dL.\" Since $2.1  2.0$, this criterion is met. This contributes $1$ point.\n\nThe total RCRI score is the sum of the points from each met criterion:\n$$ \\text{RCRI Score} = 1 (\\text{surgery type}) + 0 (\\text{IHD}) + 0 (\\text{CHF}) + 1 (\\text{CVA}) + 1 (\\text{insulin}) + 1 (\\text{creatinine}) = 4 $$\nThe patient has an RCRI score of $4$.\n\nThe next step is to map this score to the estimated probability of MACE (defined as myocardial infarction, pulmonary edema, ventricular fibrillation or primary cardiac arrest, and complete heart block) according to the original risk categories published by Lee et al.\nThe risk categories are as follows:\n-   RCRI Score $0$: Risk of MACE is $0.4\\%$\n-   RCRI Score $1$: Risk of MACE is $0.9\\%$\n-   RCRI Score $2$: Risk of MACE is $6.6\\%$\n-   RCRI Score $\\geq 3$: Risk of MACE is $11\\%$\n\nThe patient's score of $4$ falls into the highest risk category (RCRI Score $\\geq 3$). Therefore, the estimated probability of a major adverse cardiac event is $11\\%$. Expressed as a pure decimal number, this is $0.11$. To round to three significant figures as requested, the value is $0.110$.\n\nFinally, we apply the standard decision framework from professional society guidelines (e.g., American College of Cardiology/American Heart Association) regarding further noninvasive cardiac testing. The guidelines recommend a stepwise approach.\n1.  Is the surgery emergent? No, it is elective.\n2.  Does the patient have active cardiac conditions? No, this is ruled out by history, examination, and ECG.\n3.  What is the surgical risk? It is a high-risk intraperitoneal procedure.\n4.  What is the patient's functional capacity? It is poor, stated as $4$ metabolic equivalents (METs).\n5.  What is the patient's risk based on a clinical risk calculator? The RCRI score is $4$, which corresponds to a MACE risk of $11\\%$. This is considered an elevated risk (threshold is typically $1\\%$).\n\nAccording to the algorithm, for a patient with poor functional capacity ($4$ METs) and elevated clinical risk undergoing a high-risk elective surgery, one should consider the utility of further noninvasive cardiac testing (e.g., stress echocardiography, nuclear stress test). The crucial consideration is whether the results of such testing would change management. In contemporary practice, there is a strong consensus that the results are unlikely to change management. The patient has a clear indication for surgery (\"complicated diverticulitis\"). Major randomized trials have shown that preoperative coronary revascularization (e.g., stenting) in patients with stable coronary artery disease does not improve perioperative outcomes compared to optimal medical therapy alone. Therefore, even if a stress test were to reveal significant but stable ischemia, the most probable course of action would not be to subject the patient to coronary intervention before the necessary colectomy, but rather to proceed with the surgery while ensuring optimal medical management (e.g., continuation of any beta-blockers, statins, and tight glycemic control) and vigilant hemodynamic monitoring. Since the results of further testing would not alter the plan to proceed with medically optimized surgery, such testing is not warranted. The focus shifts from risk stratification to risk modification through medical management.", "answer": "$$ \\boxed{0.110} $$", "id": "4659946"}, {"introduction": "Effective preoperative optimization often involves managing specific high-risk comorbidities, such as chronic glucocorticoid use. These patients require a carefully constructed plan to balance the prevention of adrenal crisis against the risks of continued immunosuppression. This hands-on practice guides you through the design of a complete perioperative steroid protocol, from creating a multi-week taper schedule to calculating the precise stress-dose coverage, ensuring you can safely manage this common and complex clinical scenario. [@problem_id:4659755]", "problem": "A patient with ulcerative colitis has been taking a chronic daily dose of oral prednisone $20$ mg for $6$ weeks and is scheduled to undergo an elective laparoscopic total colectomy in $24$ days. The procedure is categorized as moderate surgical stress. The goals of preoperative optimization are to reduce infection and wound-healing risk by tapering supraphysiologic glucocorticoids while preventing hypothalamic-pituitary-adrenal axis suppression–related adrenal crisis perioperatively, and to provide appropriate stress-dose steroid coverage on the day of surgery.\n\nUse the following well-tested facts:\n- Chronic exposure to the equivalent of prednisone $\\geq 10$ mg daily for $\\geq 3$ weeks is associated with suppression of the hypothalamic-pituitary-adrenal axis, necessitating perioperative stress-dose glucocorticoid coverage for moderate and major surgeries.\n- Equivalency: prednisone $5$ mg is approximately equal in glucocorticoid activity to hydrocortisone $20$ mg.\n- For moderate surgical stress, a standard stress-dose regimen consists of hydrocortisone $50$ mg given intravenously at induction of anesthesia, followed by hydrocortisone $25$ mg intravenously every $8$ hours for the subsequent $24$ hours. The patient's usual morning oral glucocorticoid dose should be continued on the day of surgery.\n\nDesign a taper schedule and stress-dose steroid plan under the following constraints:\n- Beginning today (which is $24$ days prior to surgery), for doses above $12.5$ mg of prednisone daily, reduce the prednisone dose by $2.5$ mg every $7$ days.\n- Once the daily dose reaches $12.5$ mg of prednisone, reduce by $1$ mg every $3$ days until the day of surgery.\n- Administer the patient’s calculated morning-of-surgery oral prednisone dose on the day of surgery.\n\nUnder this plan, compute the total glucocorticoid exposure expressed as hydrocortisone-equivalent milligrams delivered from the time of induction of anesthesia through the first $24$ hours after induction (inclusive of the morning-of-surgery oral dose). Use the prednisone-to-hydrocortisone equivalency fact provided above. Express your final answer in milligrams of hydrocortisone, and round your answer to three significant figures.", "solution": "The problem is valid as it is scientifically grounded in established principles of clinical pharmacology and surgical endocrinology, is well-posed with a complete and consistent set of data and constraints, and is expressed in objective, formalizable language. A unique, meaningful solution can be derived through a systematic application of the provided rules.\n\nThe objective is to compute the total glucocorticoid exposure, expressed in hydrocortisone-equivalent milligrams, delivered to the patient from the time of induction of anesthesia through the first $24$ hours post-induction. This total dose is the sum of two components:\n$1$. The patient's oral prednisone dose taken on the morning of surgery, converted to its hydrocortisone equivalent.\n$2$. The total intravenous (IV) hydrocortisone administered as a stress-dose regimen over the specified $24$-hour period.\n\nFirst, we must determine the patient's oral prednisone dose on the day of surgery. The taper starts today, which is $24$ days prior to surgery (Day $-24$), with the day of surgery being Day $0$. The initial daily dose is $20$ mg of prednisone.\n\nThe tapering schedule is defined by two rules:\n- Rule $1$: For doses above $12.5$ mg, reduce the dose by $2.5$ mg every $7$ days.\n- Rule $2$: Once the dose reaches $12.5$ mg or less, reduce by $1$ mg every $3$ days.\n\nLet $D(t)$ be the daily dose on day $t$.\nThe initial dose is $D(t) = 20$ mg for $t \\in [-24, -18]$.\nThe first dose reduction occurs after $7$ days, so the new dose is effective on Day $-17$.\nDose on Day $-17$: $20 \\text{ mg} - 2.5 \\text{ mg} = 17.5$ mg. This dose is held for $7$ days.\nThe second dose reduction occurs on Day $-17+7 = -10$.\nDose on Day $-10$: $17.5 \\text{ mg} - 2.5 \\text{ mg} = 15.0$ mg. This dose is held for $7$ days.\nThe third dose reduction occurs on Day $-10+7 = -3$.\nDose on Day $-3$: $15.0 \\text{ mg} - 2.5 \\text{ mg} = 12.5$ mg.\n\nAt this point, the dose has reached $12.5$ mg, so Rule $2$ applies for subsequent tapering. The rule states a reduction of $1$ mg every $3$ days. Since the dose was set to $12.5$ mg on Day $-3$, the next scheduled reduction is $3$ days later, on Day $-3+3 = 0$.\nTherefore, on the morning of surgery (Day $0$), the dose is reduced.\nThe calculated dose for Day $0$ is: $12.5 \\text{ mg} - 1 \\text{ mg} = 11.5$ mg.\nThe oral dose taken on the morning of surgery is $11.5$ mg of prednisone.\n\nNext, we convert this oral prednisone dose to its hydrocortisone equivalent. The problem provides the equivalency: $5$ mg prednisone is equivalent to $20$ mg hydrocortisone.\nThe conversion factor is $\\frac{20 \\text{ mg hydrocortisone}}{5 \\text{ mg prednisone}} = 4$.\nThe hydrocortisone equivalent ($HC_{oral}$) of the morning oral dose is:\n$$HC_{oral} = 11.5 \\text{ mg prednisone} \\times 4 = 46 \\text{ mg hydrocortisone}$$\n\nNow, we calculate the total IV hydrocortisone administered during the perioperative period. The regimen for moderate surgical stress is:\n- $50$ mg IV hydrocortisone at induction of anesthesia (at time $t=0$).\n- $25$ mg IV hydrocortisone every $8$ hours for the subsequent $24$ hours.\n\nThe doses after induction occur at $8$ hours, $16$ hours, and $24$ hours. This constitutes $3$ doses.\nThe total IV hydrocortisone dose ($HC_{IV}$) is:\n$$HC_{IV} = 50 \\text{ mg} + (3 \\times 25 \\text{ mg}) = 50 \\text{ mg} + 75 \\text{ mg} = 125 \\text{ mg hydrocortisone}$$\n\nFinally, the total glucocorticoid exposure in hydrocortisone-equivalent milligrams is the sum of the oral equivalent dose and the total IV dose.\n$$HC_{total} = HC_{oral} + HC_{IV}$$\n$$HC_{total} = 46 \\text{ mg} + 125 \\text{ mg} = 171 \\text{ mg hydrocortisone}$$\n\nThe problem requires the final answer to be rounded to three significant figures. The calculated value of $171$ already consists of three significant figures ($1$, $7$, and $1$). Therefore, no further rounding is necessary.\nThe total glucocorticoid exposure is $171$ mg of hydrocortisone equivalent.", "answer": "$$\\boxed{171}$$", "id": "4659755"}]}